Hyundai Bioscience Market Cap

Hyundai Bioscience has a market cap or net worth of 697.24 billion as of July 18, 2025. Its market cap has decreased by -1.85% in one year.

Market Cap

697.24B

Enterprise Value

641.38B

Revenue

10.71B

Ranking

n/a

PE Ratio

n/a

Stock Price

14,520.00

Market Cap Chart

Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 697.24B, an increase of 1,368.06%. That is a compound annual growth rate of 12.75%.

Market Cap History

Date	Market Cap	% Change
Jul 18, 2025	697.24B	24.10%
Dec 30, 2024	561.85B	-45.92%
Dec 28, 2023	1,038.98B	-4.44%
Dec 29, 2022	1,087.24B	11.39%
Dec 30, 2021	976.10B	-6.92%
Dec 30, 2020	1,048.68B	115.45%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.80T
Celltrion	39.82T
ALTEOGEN	26.19T
Yuhan	9,866.54B
SK Biopharmaceuticals	8,066.26B
HLB Co., Ltd.	6,939.04B
Peptron	6,861.07B
PharmaResearch	5,890.93B

Market Cap Rankings